ACE2 and Crohn disease: With respect to other immune-mediated inflammatory diseases, Potdar et al. (19) found increased expression of ACE2 in active ulcerative colitis (UC) and low small bowel expression of ACE in Crohn’s disease (CD) compared to controls.